This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Valentini G, Black C . Systemic sclerosis. Best Pract Res Clin Rheumatol 2002; 16: 807–816.
Bryan C, Knight C, Black CM, Silman AJ . Prediction of five-year survival following presentation with scleroderma – development of a simple model using three disease factors at first visit. Arthr Rheumat 1999; 42: 2660–2665.
Binks M, Passweg JR, Furst D et al. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease (comment). Ann Rheumat Dis 2001; 60: 577–584.
McSweeney PA, Nash RA, Sullivan KM et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood 2002; 100: 1602–1610.
Farge D, Marolleau JP, Zohar S et al. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I–II study. Br J Haematol 2002; 119: 726–739.
Barton JC, Saway DA, Blackburn WD et al. Thrombotic thrombocytopenic purpura in systemic sclerosis. J Rheumatol 1989; 16: 1400–1401.
Kfoury Baz EM, Mahfouz RA, Masri AF, Jamaleddine GW . Thrombotic thrombocytopenic purpura in a case of scleroderma renal crisis treated with twice-daily therapeutic plasma exchange. Renal Failure 2001; 23: 737–742.
Steen VD, Medsger Jr TA . Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthr Rheumat 1998; 41: 1613–1619.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
David, S., Englert, H., Furlong, T. et al. Red cell fragmentation preceding a renal crisis in a patient with systemic sclerosis undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant 35, 629–630 (2005). https://doi.org/10.1038/sj.bmt.1704832
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704832